 Fatty acid elongases desaturases play important role hepatic whole body lipid composition. examined role key transcription factors played control hepatic elongase desaturase expression. Studies peroxisome proliferator-activated receptor alpha (PPARalpha)-deficient mice establish PPARalpha required WY14643-mediated induction fatty acid elongase-5 (Elovl-5), Elovl-6, three desaturases [Delta(5) desaturase (Delta(5)D), Delta(6)D, Delta(9)D]. Increased nuclear sterol-regulatory element binding protein-1 (SREBP-1) correlated enhanced expression Elovl-6, Delta(5)D, Delta(6)D, Delta(9)D. Delta(9)D also regulated independently liver X receptor (LXR) agonist. Glucose induction l-type pyruvate kinase, Delta(9)D, Elovl-6 expression required carbohydrate-regulatory element binding protein/MAX-like factor X (ChREBP/MLX) heterodimer. Suppression Elovl-6 Delta(9)D expression livers streptozotocin-induced diabetic rats high fat-fed glucose-intolerant mice correlated low levels nuclear SREBP-1. leptin-deficient obese mice (Lep(ob/ob)), increased SREBP-1 MLX nuclear content correlated induction Elovl-5, Elovl-6, Delta(9)D expression massive accumulation monounsaturated fatty acids (18:1,n-7 18:1,n-9) neutral lipids. Diabetes- obesity-induced changes hepatic lipid composition correlated changes elongase desaturase expression. conclusion, studies establish role PPARalpha, LXR, SREBP-1, ChREBP, MLX control hepatic fatty acid elongase desaturase expression lipid composition.